Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
OPKO Health is a diversified healthcare company specializing in pharmaceuticals, diagnostics, and biologics. It develops and commercializes therapies like long-acting growth hormone (NGENLA) and treatments for kidney disease, while operating diagnostic labs and advanced biotech pipelines. Its core markets include the U.S., Europe, Asia, and Latin America, leveraging proprietary technologies, strategic partnerships, and a global footprint to address unmet medical needs in endocrinology, oncology, infectious diseases, and personalized medicine.
This description was generated via AI from an annual report. Updated about 1 year ago.